استخدام الليدوكائين مع أدوية المباشرة عند مرضى فرط التوتر الشرياني

Authors

  • تيسير ابراهيم
  • رزق الله ابراهيم
  • خالد ابراهيم

Abstract

  • ارتفاع التوتر الشرياني مرض شائع ومنتشر عالمياً، يصيب كلا الجنسين، ويزداد حدوثه مع تقدم العمر.
  • شملت دراستنا (60) مريضاً من المقبولين في مشفى الأسد الجامعي باللاذقية, وذلك خلال الفترة الممتدة ما بين 24/1/2006 ولغاية 28/3/2007 والمشخص لديهم ارتفاع توتر شرياني سابق.
  • بلغ عدد الإناث في عينة الدراسة (35) بنسبة (58%) وعدد الذكور (25) بنسبة (42%).
  • لقد قمنا بتقسيم مرضى الدراسة إلى مجموعتين, وذلك بناءاً على استخدام الليدوكائين قبل التنبيب الرغامي:

مجموعة A أعطيت الليدوكائين قبل التنبيب الرغامي وتشكل (30) مريضاً.

مجموعة B لم تعطَ الليدوكائين قبل التنبيب الرغامي وتشكل (30) مريضاً.

  • وقد تم تقييم شدة الارتكاسات الرافعة للضغط, واضطرابات النظم التالية للتنبيب الرغامي لدى مرضى فرط التوتر الشرياني من لحظة التنبيب الرغامي وحتى مرور (5) دقائق على المباشرة.
  • تبين لنا بالنتيجة أن استخدام الليدوكائين قبل التنبيب الرغامي عند مرضى فرط التوتر الشرياني أدى إلى الحد من الارتكاسات الرافعة للضغط, واضطرابات النظم التالية للتنبيب الرغامي.
    • Hypertension is a common disease world-wide. It involves both sexes, all ages, and its incidence increases proportionally with age.
    • Our study included 60 patients from those who were admitted to AL-ASSAD university hospital (LATTAKIA) from 24/1/2006 to 28/3/2007. They were diagnosed as hypertensive patients.
    • The female patients were 35 (58%) and the male ones 25 (42%).
    • We divided our patients into two groups, according to the Lidocaine medication before the intubation.

Group A account 30 patients which received Lidocaine before intubation

Group B accounts 30 patients which did not receive Lidocaine before intubation.

  • We have evaluated the severity of the hypertensive reaction and dysarrhythmias induced by the intubation in the hypertensive patients upon the intubation and after 5 minutes of induction.
  • The result of our study was that the use of lidocaine before intubation in the hypertensive patients caused reduction of the hypertensive reactions and dysarrhythmias induced by the intubation.

Downloads

Published

2019-01-16

How to Cite

1.
ابراهيم ت, ابراهيم را, ابراهيم خ. استخدام الليدوكائين مع أدوية المباشرة عند مرضى فرط التوتر الشرياني. Tuj-hlth [Internet]. 2019Jan.16 [cited 2024Apr.18];29(3). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6481

Issue

Vol. 29 No. 3 (2007): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)